Related Experiment Video

Updated: Jun 26, 2026

Functional Interrogation of Adult Hypothalamic Neurogenesis with Focal Radiological Inhibition
11:45

Functional Interrogation of Adult Hypothalamic Neurogenesis with Focal Radiological Inhibition

Published on: November 14, 2013

Ageing abolishes the effects of fluoxetine on neurogenesis

S Couillard-Despres1, C Wuertinger, M Kandasamy

  • 1Department of Neurology, University of Regensburg, Regensburg D-93053, Germany. sebastien.couillard-despres@klinik.uni-regensburg.de

Molecular Psychiatry
|January 14, 2009
PubMed

Insights

Antidepressant fluoxetine boosts hippocampal neurogenesis only in young mice. Its effects diminish with age, indicating age-dependent therapeutic mechanisms in elderly patients.

Area of Science:

  • Neuroscience
  • Gerontology
  • Pharmacology

Background:

  • Depression is common in the elderly.
  • Antidepressants can stimulate neurogenesis in young animals.
  • Aging reduces neurogenesis rates.

Purpose of the Study:

  • To investigate how aging affects the neurogenic actions of antidepressants.
  • To determine if fluoxetine's impact on neurogenesis varies with age.

Main Methods:

  • Fluoxetine was administered daily to mice aged 100, 200, and over 400 days.
  • Hippocampal neurogenesis was assessed by analyzing cell proliferation, survival, and neuronal differentiation.
  • Changes in neurogenesis were compared across different age groups.

Main Results:

  • Fluoxetine significantly increased cell survival and neuronal marker expression in young adult mice (100 days old) only.
  • No significant effects of fluoxetine on hippocampal neurogenesis were observed in adult (200 days) or elderly mice (>400 days).
  • The neurogenic effect of fluoxetine decreased with increasing age.

Conclusions:

  • Fluoxetine's ability to modulate hippocampal neurogenesis is age-dependent.
  • The therapeutic benefits of antidepressants in elderly individuals may not involve neurogenesis.
  • Further research is needed to understand age-related antidepressant efficacy.

More Related Videos

Preparation of Acute Hippocampal Slices from Rats and Transgenic Mice for the Study of Synaptic Alterations during Aging and Amyloid Pathology14:57

Preparation of Acute Hippocampal Slices from Rats and Transgenic Mice for the Study of Synaptic Alterations during Aging and Amyloid Pathology

Published on: March 23, 2011

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...